uric acid has been researched along with Bone Spur in 4 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A metabolic syndrome (MetS) is accompanied by hyperuricemia, during which xanthine oxidoreductase (XOR) catalyzes the production of uric acid." | 3.83 | Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis. ( Aibibula, Z; Ailixiding, M; Asou, Y; Hara, Y; Iwata, M; Okawa, A; Piao, J, 2016) |
| "Tophaceous gout is a common arthritis caused by the deposition of urate crystals and is related to limited joint function." | 1.91 | Interplay between fat, muscle, bone mass, and oteophytes and risk for tophaceous gout. ( Chen, YC; Hsu, CC; Hsu, CM; Huang, CC; Wu, RW, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, CM | 1 |
| Hsu, CC | 1 |
| Wu, RW | 1 |
| Huang, CC | 1 |
| Chen, YC | 1 |
| Sakaguchi, S | 1 |
| Dalbeth, N | 1 |
| Aati, O | 1 |
| Kalluru, R | 1 |
| Gamble, GD | 1 |
| Horne, A | 1 |
| Doyle, AJ | 1 |
| McQueen, FM | 1 |
| Aibibula, Z | 1 |
| Ailixiding, M | 1 |
| Iwata, M | 1 |
| Piao, J | 1 |
| Hara, Y | 1 |
| Okawa, A | 1 |
| Asou, Y | 1 |
4 other studies available for uric acid and Bone Spur
| Article | Year |
|---|---|
Interplay between fat, muscle, bone mass, and oteophytes and risk for tophaceous gout.
Topics: Adipose Tissue; Aged; Bone Density; Case-Control Studies; Cross-Sectional Studies; Gout; Humans; Mal | 2023 |
Repair of Bone Erosion With Effective Urate-Lowering Therapy in a Patient With Tophaceous Gout.
Topics: Benzbromarone; Bone Resorption; Enzyme Inhibitors; Gout; Humans; Male; Metatarsal Bones; Metatarsoph | 2021 |
Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Aged, 80 and over; Ankylosis; Female; Foot Joints; | 2015 |
Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis.
Topics: Adipose Tissue; Animals; Apoptosis; Carrier Proteins; Chondrocytes; Diet, High-Fat; Enzyme Activatio | 2016 |